Berenberg Bank reissued their buy rating on shares of Begbies Traynor Group (LON:BEG – Free Report) in a research note published on Thursday morning, Marketbeat.com reports. The firm currently has a GBX 150 ($1.89) price target on the stock.
Several other analysts have also weighed in on the stock. Canaccord Genuity Group raised their price objective on shares of Begbies Traynor Group from GBX 148 ($1.87) to GBX 150 ($1.89) and gave the stock a “buy” rating in a report on Tuesday, December 10th. Shore Capital reiterated a “house stock” rating on shares of Begbies Traynor Group in a research report on Tuesday, December 10th.
Get Our Latest Analysis on Begbies Traynor Group
Begbies Traynor Group Stock Down 3.0 %
Insider Transactions at Begbies Traynor Group
In other news, insider Graham McInnes sold 137,200 shares of the stock in a transaction on Tuesday, October 29th. The stock was sold at an average price of GBX 92 ($1.16), for a total value of £126,224 ($159,313.39). 26.47% of the stock is currently owned by corporate insiders.
About Begbies Traynor Group
Begbies Traynor Group plc provides various professional services to businesses, professional advisors, large corporations, and financial institutions in the United Kingdom. The company operates through two segments: Insolvency and Advisory Services; and Property Advisory and Transactional Services. It offers business rescue and recovery services, including company administration, creditors' voluntary liquidation, company dissolution and strike off, company voluntary arrangement, compulsory liquidation, the Law of Property Act or fixed charge receiverships, members' voluntary liquidation, partnership liquidation, and personal insolvency services, as well as closure options for insolvent companies.
Featured Stories
- Five stocks we like better than Begbies Traynor Group
- How Technical Indicators Can Help You Find Oversold Stocks
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Texas Instruments: The Old-School Tech Titan Still Delivering
- The How and Why of Investing in Gold Stocks
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Begbies Traynor Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Begbies Traynor Group and related companies with MarketBeat.com's FREE daily email newsletter.